Commentary: bias among Patient representatives on FDA panels questioned
15 April 2009
Sue Sutter
Please Login to read the full article.
15 April 2009
Sue Sutter
sue.sutter@informa.com
The US FDA has frequently faced criticism that it has not done enough to screen advisory panel members for potential pro-industry biases, or that it "stacked the deck" with experts who are unlikely to be critical of a new drug under review.
Such was the public relations fall-out when the...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
